Stay updated on Cusatuzumab Combo in AML: Clinical Trial
Sign up to get notified when there's something new on the Cusatuzumab Combo in AML: Clinical Trial page.

Latest updates to the Cusatuzumab Combo in AML: Clinical Trial page
- Check7 days agoChange DetectedAdditional history versions were added to the Record History page, expanding past submissions and updates including study status and contact/location details.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check36 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference9%

- Check43 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

- Check57 days agoChange DetectedVersion bumped to v3.0.2 and the previous v3.0.1 tag removed; a minor UI element ('Back to Top') was also removed.SummaryDifference0.6%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.6%

- Check71 days agoChange DetectedThe web page has added a facility name and location details, including specific study statuses and outcome measures, while removing certain location-related terms and identifiers.SummaryDifference49%

Stay in the know with updates to Cusatuzumab Combo in AML: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cusatuzumab Combo in AML: Clinical Trial page.